Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongcai Chen

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Sensors (Basel, Switzerland)|April 25, 2014
An interactive control algorithm used for equilateral triangle formation with robotic sensorsXiang Li, Hongcai Chen
Frontiers in Oncology|January 29, 2024
Cost-effectiveness analysis of serplulimab combination therapy versus chemotherapy alone for patients with extensive-stage small cell lung cancerZhiwei Zheng, Hongcai Chen, Hongfu Cai
RSC Advances|May 11, 2022
Insight into catalytic reduction of CO<sub>2</sub> to methane with silanes using Brookhart's cationic Ir(iii) pincer complexShaoqin Fang, Hongcai Chen, Haiyan Wei
Minerva Pediatrics|May 11, 2023
Clinical study of auricular point pressing bean combined with tropisetron in the treatment of chemotherapy-related gastrointestinal reactionsHongcai Chen, Tingting Tan, Cui Yang, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|November 30, 2023
First-Line Tislelizumab for Advanced or Metastatic Esophageal Squamous Cell Carcinoma:A Cost-Effectiveness AnalysisZhiwei Zheng, Hongcai Chen, Hongfu Cai, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 1, 2023
Trastuzumab deruxtecan versus chemotherapy treated in patients with HER2-positive metastatic breast cancer: a cost-effectiveness analysis based on the DESTINY-Breast02 trialZhiwei Zheng, Hongcai Chen, Hongfu Cai, et al.
Frontiers in Immunology|July 16, 2025
Toripalimab plus chemotherapy versus chemotherapy as first-line therapy for extensive-stage small cell lung cancer: a cost-effectiveness analysisLongfeng Zhang, Hongcai Chen, Huide Zhu, et al.
African Journal of Reproductive Health|March 3, 2026
The cognitive impact of AI-generated content on sexual and reproductive health cognition among women in Africa and Latin America: opportunities, challenges, and future pathsYan Wang, Shuai Yuan, Xinjie Lin, et al.
Scientific Reports|March 29, 2025
Machine learning based intratumor heterogeneity related signature for prognosis and drug sensitivity in breast cancerHongcai Chen, Minna Chen, Cui Yang, et al.
Frontiers in Cell and Developmental Biology|October 13, 2025
Machine learning based immune evasion signature for predicting the prognosis and immunotherapy benefit in stomach adenocarcinomaWenwu Xue, Guanglin Zhang, Cui Yang, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Sensors (Basel, Switzerland)|April 25, 2014
An interactive control algorithm used for equilateral triangle formation with robotic sensorsXiang Li, Hongcai Chen
Frontiers in Oncology|January 29, 2024
Cost-effectiveness analysis of serplulimab combination therapy versus chemotherapy alone for patients with extensive-stage small cell lung cancerZhiwei Zheng, Hongcai Chen, Hongfu Cai
RSC Advances|May 11, 2022
Insight into catalytic reduction of CO<sub>2</sub> to methane with silanes using Brookhart's cationic Ir(iii) pincer complexShaoqin Fang, Hongcai Chen, Haiyan Wei
Minerva Pediatrics|May 11, 2023
Clinical study of auricular point pressing bean combined with tropisetron in the treatment of chemotherapy-related gastrointestinal reactionsHongcai Chen, Tingting Tan, Cui Yang, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|November 30, 2023
First-Line Tislelizumab for Advanced or Metastatic Esophageal Squamous Cell Carcinoma:A Cost-Effectiveness AnalysisZhiwei Zheng, Hongcai Chen, Hongfu Cai, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 1, 2023
Trastuzumab deruxtecan versus chemotherapy treated in patients with HER2-positive metastatic breast cancer: a cost-effectiveness analysis based on the DESTINY-Breast02 trialZhiwei Zheng, Hongcai Chen, Hongfu Cai, et al.
Frontiers in Immunology|July 16, 2025
Toripalimab plus chemotherapy versus chemotherapy as first-line therapy for extensive-stage small cell lung cancer: a cost-effectiveness analysisLongfeng Zhang, Hongcai Chen, Huide Zhu, et al.
African Journal of Reproductive Health|March 3, 2026
The cognitive impact of AI-generated content on sexual and reproductive health cognition among women in Africa and Latin America: opportunities, challenges, and future pathsYan Wang, Shuai Yuan, Xinjie Lin, et al.
Scientific Reports|March 29, 2025
Machine learning based intratumor heterogeneity related signature for prognosis and drug sensitivity in breast cancerHongcai Chen, Minna Chen, Cui Yang, et al.
Frontiers in Cell and Developmental Biology|October 13, 2025
Machine learning based immune evasion signature for predicting the prognosis and immunotherapy benefit in stomach adenocarcinomaWenwu Xue, Guanglin Zhang, Cui Yang, et al.
Pageof 2